Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
2021 · International Journal of Infectious Diseases · 100 citations
https://doi.org/10.1016/j.ijid.2021.08.008
H
Hanaa Nafady‐Hego
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
721
Citations
14
h-index
17
i10-index
Hanaa Nafady‐Hego is an academic researcher from Assiut University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Immune Cell Function and Interaction. The author has an h-index of 14, co-authored 49 publications.
ORCID: 0000-0002-5562-0245Papers by this author
worksShort term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
2021 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-021-88086-x
SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term
2021 · BMC Public Health · 3 citations
https://doi.org/10.1186/s12889-021-12134-4
Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar
2024 · Clinical Epidemiology and Global Health · 2 citations
https://doi.org/10.1016/j.cegh.2024.101843
SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare system
2024 · Global Epidemiology · 0 citations
https://doi.org/10.1016/j.gloepi.2024.100149
A prospective cluster randomized trial of an interventions bundle to reduce inappropriate antibiotic use for upper respiratory tract infections in the outpatient setting
2025 · BMC Infectious Diseases · 0 citations
https://doi.org/10.1186/s12879-025-11210-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat